Turning Data into Clinical Insight

Powered by the most advanced AI algorithms, Fabric’s software speeds up diagnostics across a range of clinical applications.

A dual image with child on top and a male and female couple on the bottom.

Scalable genomic analysis

Fabric offers a comprehensive genomic analysis platform that takes you from sample to evidence-backed analysis to clinical report with confidence. Use Fabric’s implementation and clinical services to ensure your success.

90%

Faster
clinical review

15min

WGS/WES
analysis

99.9%

Pathogenic variant
classification for panels

Enabling precision medicine with AI-driven interpretation

For all NGS testing from whole genomes and exomes to targeted panels

Fabric Genomics offers the leading AI-based platform for NGS analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing with best-in-class accuracy and scalability.

Dozens of the worlds leading hospitals, clinical labs, and academic centers such as Cincinnati Children’s, InterMountain, Rady Children’s Institute, LabCorp, and others count on Fabric AI technology and Fabric’s clinical services for their complete NGS software and services needs.

Fabric is the solution of choice for leading genomics programs around the world
Why Fabric?
Accuracy &
Diagnostic Yield
  • 98% of causal variants ranked in the top 5 by GEM for rare disease
  • ACMG-compliant classification backed by validation across
    > 50,000 variants
Scalability
& Efficiency
  • 10 times more cases with the same team
  • Average clinical review time of 15min for WGS
  • Optimized workflow for efficient throughput, secure, API integration with LIMS & EMR
Comprehensive Software
& Services
  • Get up and running in as little as 4 weeks
  • Software Set up & Lab Validation
  • Panel curation and SOP design
  • Interpretation and signout
Martin Reese

Martin Reese, Ph.D.

Co-Founder, President, Board Member, and CEO

John Stuelpnagel

John Stuelpnagel, D.V.M

Co-Founder, Chairman of the Board of Directors

Jim Tananbaum

Jim Tananbaum, M.D.

Board Member

Paul Billings

Paul Billings, M.D., Ph.D.

Co-Founder & Acting Chief Medical Officer

Sean Hofherr, PhD, FACMG

Chief Operating Officer and Clinical Director

Michael Vishnevetsky, Ph.D.

Vice President of Business Development

Joe Azure

Joe Azure

Vice President of Software Engineering

Erwin Frise, Ph.D.

Vice President of Bioinformatics & Data Science